A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients
NCT ID: NCT02869269
Last Updated: 2018-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2015-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Colon Cancer
NCT02567942
Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients
NCT06454071
Immune Response in Peripheral Blood of Patients With Colon Cancer
NCT00900432
Tumoral Circulating Cells and Colorectal Cancer Progression
NCT03256084
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
NCT00625625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Early (stage1+2) and Late(stage3+4)
2. regional lymph node metastasis
3. Distant metastasis
4. TNM stage
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early stage
patients who diagnosed as TNM stage 1 and 2
Early stage
patients who classed as clinical stage 1 and 2
Late stage
patients who diagnosed as TNM stage 3 and 4
Late stage
patients who classed as clinical stage 3 and 4
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early stage
patients who classed as clinical stage 1 and 2
Late stage
patients who classed as clinical stage 3 and 4
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of hypersensitivity reaction in propofol or sevoflurane
* history of previous cancer
* patient with ongoing inflammation
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konkuk University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seong-Hyop Kim
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seong-Hyop Kim, M.D,Ph.D
Role: PRINCIPAL_INVESTIGATOR
Konkuk University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Konkuk University Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH1160096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.